66
Views
25
CrossRef citations to date
0
Altmetric
Research Article

G-CSF Administered in Time-sequenced Setting During Remission Induction and Consolidation Therapy of Adult Acute Lymphoblastic Leukemia has Beneficial Influence on Early Recovery and Possibly Improves Long-term Outcome: A Randomized Multicenter Study

, , , , , , , , , , , , , , , , , & show all
Pages 315-325 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Helene Hallböök, Magnus Björkholm, Hans Hägglund & Bengt Smedmyr. (2009) Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?. Leukemia & Lymphoma 50:11, pages 1872-1874.
Read now
Sebastian Giebel, Jerzy Holowiecki, Malgorzata Krawczyk-Kulis, Krystyna Jagoda, Beata Stella-Holowiecka, Maria Sadus-Wojciechowska, Andrzej Hellmann, Anna Dmoszynska, Monika Paluszewska, Tadeusz Robak, Lech Konopka, Ilona Seferynska, Aleksander B. Skotnicki, Slawomira Kyrcz-Krzemien & on Behalf of the Polish Adult Leukemia Group (Palg). (2009) Impact of granulocyte colony stimulating factor administered during induction and consolidation of adults with acute lymphoblastic leukemia on survival: long-term follow-up of the Polish adult leukemia group 4-96 study. Leukemia & Lymphoma 50:6, pages 1050-1053.
Read now

Articles from other publishers (22)

Ryan W. Jacobs, Omotayo Fasan, Edward A. Copelan & Belinda R. Avalos. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 1247 1262 .
Elkin Javier Casadiego Rincón, Jorge Augusto Díaz Rojas, Carlos Daniel Bermúdez & Víctor Prieto Martínez. (2016) Costo- Efectividad Del Uso Profiláctico Del Factor Estimulante De Colonias De Granulocitos En Adultos Con Leucemia Linfoblástica Aguda en Colombia. Value in Health Regional Issues 11, pages 9-16.
Crossref
Nicole Skoetz, Julia Bohlius, Andreas Engert, Ina Monsef, Oliver Blank & Jörg-Janne Vehreschild. (2015) Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. Cochrane Database of Systematic Reviews 2015:12.
Crossref
Katherine Linder, Deepthi Gandhiraj, Madhura Hanmantgad, Karen Seiter & Delong Liu. (2016) Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: hyperCVAD, high dose cytarabine mitoxantrone and CLAG. Experimental Hematology & Oncology 5:1.
Crossref
SHI-GUANG YE, YI DING, LIANG LI, MENG YANG, WEN-JUN ZHANG & AI-BIN LIANG. (2015) Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia. Molecular and Clinical Oncology 3:3, pages 730-736.
Crossref
J.J. Vehreschild, A. Böhme, O.A. Cornely, C. Kahl, M. Karthaus, K.-A. Kreuzer, G. Maschmeyer, S. Mousset, V. Ossendorf, O. Penack, M.J.G.T. Vehreschild & J. Bohlius. (2014) Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy—evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO). Annals of Oncology 25:9, pages 1709-1718.
Crossref
Ilja Striz, Eva Brabcova, Libor Kolesar & Alena Sekerkova. (2014) Cytokine networking of innate immunity cells: a potential target of therapy. Clinical Science 126:9, pages 593-612.
Crossref
Belinda R. Avalos & Edward A. Copelan. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 1347 1361 .
Sebastian Giebel, Xavier Thomas, Helene Hallbook, Klaus Geissler, Jean-Michel Boiron, Francoise Huguet, Elisabeth Koller, Ulrich Jaeger, Bengt Smedmyr, Andrzej Hellmann & Jerzy Holowiecki. (2012) The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALL. European Journal of Cancer 48:3, pages 360-367.
Crossref
Gillian M. Keating. (2011) Lenograstim. Drugs 71:6, pages 679-707.
Crossref
Xavier Thomas. 2010. Leukemias: Principles and Practice of Therapy. Leukemias: Principles and Practice of Therapy 193 216 .
S Giebel, B Stella-Holowiecka, M Krawczyk-Kulis, N Gökbuget, D Hoelzer, M Doubek, J Mayer, B Piatkowska-Jakubas, A B Skotnicki, H Dombret, J M Ribera, P P Piccaluga, T Czerw, S Kyrcz-Krzemien & J Holowiecki. (2009) Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL. Bone Marrow Transplantation 45:6, pages 1095-1101.
Crossref
Michael Heuser, Arnold Ganser & Dieter Hoelzer. 2011. Hematopoietic Growth Factors in Oncology. Hematopoietic Growth Factors in Oncology 339 362 .
Olga Frankfurt & Martin S. Tallman. 2011. Hematopoietic Growth Factors in Oncology. Hematopoietic Growth Factors in Oncology 307 337 .
Oliver G. Ottmann, Gesine Bug & Jürgen Krauter. (2007) Current Status of Growth Factors in the Treatment of Acute Myeloid and Lymphoblastic Leukemia. Seminars in Hematology 44:3, pages 183-192.
Crossref
M. R. Nowrousian, M. Poser & O. Kloke. 2007. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 1405 1430 .
Sebastian Giebel, Malgorzata Krawczyk-Kulis, Maria Adamczyk-Cioch, Beata Jakubas, Grazyna Palynyczko, Krzysztof Lewandowski, Anna Dmoszynska, Aleksander Skotnicki, Katarzyna Nowak & Jerzy Holowiecki. (2006) Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG). Annals of Hematology 85:10, pages 717-722.
Crossref
F Ravandi. (2006) Role of cytokines in the treatment of acute leukemias: a review. Leukemia 20:4, pages 563-571.
Crossref
Farhad Ravandi & Partow Kebriaei. 2005. Cytokines and Cancer. Cytokines and Cancer 313 331 .
J Holowiecki, S Grosicki, T Robak, S Kyrcz-Krzemien, S Giebel, A Hellmann, A Skotnicki, W W Jedrzejczak, L Konopka, K Kuliczkowski, B Zdziarska, A Dmoszynska, B Marianska, A Pluta, K Zawilska, M Komarnicki, J Kloczko, K Sulek, O Haus, B Stella-Holowiecka, W Baran, B Jakubas, M Paluszewska, A Wierzbowska, M Kielbinski & K Jagoda. (2004) Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. Leukemia 18:5, pages 989-997.
Crossref
C. Nieder, B. Jeremic, F. B. Zimmermann & T. Licht. 2003. Modification of Radiation Response. Modification of Radiation Response 103 111 .
. (2002) Current Awareness in Hematological Oncology. Hematological Oncology 20:4, pages 189-196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.